Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03317119
Title Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications

rectum cancer

colon cancer

Therapies

Trametinib + Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST